Ohio State University Comprehensive Cancer Center

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Comparing an Operation to Monitoring, With or Without Endocrine Therapy (COMET) Trial For Low Risk DCIS	Carcinoma, Ductal, Neoplasms by Histologic Type, Neoplasms, Ductal, Lobular, and Medullary, adenocarcinoma, breast carcinoma in situ, carcinoma, ductal breast carcinoma in situ, epithelial neoplasm, in situ carcinoma, neoplasm	Active, not recruiting	Not applicable	2026-05-12		NCT02926911
Pacritinib in Relapsed/Refractory T-cell Lymphoproliferative Neoplasms	Hemic and Lymphatic Diseases, T-cell and NK-cell neoplasm, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoproliferative syndrome	Recruiting	Phase 2	2026-01-29		NCT04858256

Clinical trials